Carbosayoka 150mg Injection
Marketer
Sayoka Pharmaceutical (OPC) Pvt Ltd
Salt Composition
Carboplatin (150mg)
Overview Carbosayoka 150mg Injection
Oncaspray 150mg Injection treats ovarian and small-cell lung cancers by inhibiting or reducing cancer cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Benefits may take weeks or months to appear; discontinue only under medical guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitor blood cell levels, heart, liver function, and uric acid. Report any allergic reaction (rash, itching, breathing difficulties). Inform your doctor of all other medications you take, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.
Uses of Carbosayoka 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Carbosayoka 150mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Carbosayoka 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carbosayoka 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Carbosayoka 150mg Injection works:
Oncasin 150mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the genetic building blocks (DNA and RNA) within cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Carbosayoka 150mg Injection and alcohol is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carbosayoka 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Carbosayoka 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Carbosayoka 150mg Injection might induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Carbosayoka 150mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Kidney function should be regularly monitored during treatment with Carbosayoka 150mg Injection.
LiverSAFE IF PRESCRIBED
The use of Carbosayoka 150mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Carbosayoka 150mg Injection :
Should you forget a Carbosayoka 150mg Injection, seek medical advice.
Facts to Know About Carbosayoka 150mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Platinum-based Anticancer Agents |
3,018 People bought this recently